-$100 Loss
ONTXLong Stock
pm trade
Entry comments: XGPT pick. News - Onconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’s. Consolidation Days: 61 - The stock shows strong consolidation behaviour after the specified number of days since the last breakout. This suggests that the stock may have ended its consolidation phase and is ready to break out. Goal 10-12% Profit.
Exit comments: XGPT continues to show this as a pick verdict day after day. Volume just isn't there. Held on for the week. Taking a small loss now.
Broker:ETrade
$172 Profit
ONTXLong Stock
Dropped immediately after entering trade, should have cut losses more quickly
$204 Profit
ONTXShort Stock
$72 Profit
ONTXShort Stock
$1,060 Profit
ONTXShort Stock
$26 Profit
ONTXLong Stock
*Results may not be typical and may vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here.
Never attempt to copy or mirror the trades discussed on this website or in alerts. Attempting to do so may result in substantial financial losses. Alerts are not provided in real-time. For that reason, it is highly unlikely you will be able to buy the stocks at the same entry price, or sell the stocks at the same exit price, to achieve the same or similar profits obtained.
Never attempt to copy or mirror the trades discussed on this website or in alerts. Attempting to do so may result in substantial financial losses. Alerts are not provided in real-time. For that reason, it is highly unlikely you will be able to buy the stocks at the same entry price, or sell the stocks at the same exit price, to achieve the same or similar profits obtained.
